Introduction {#sec1}
============

Ongoing progress in modern chemical synthesis depends on the invention of new transformations that allow a target-relevant increase in complexity without the generation of byproducts or atomic waste.^[@ref1]^ In this context, the functionalization of "inert" C--H bonds using transition-metal catalysis represents a particularly appealing strategy.^[@ref2]^ Most of the C--H activation reactions consist of couplings, cyclization, and halogenation or acetoxylation processes. However, in recent years, there has been an increasing number of reports on processes that couple the C--H activation with a formal cycloaddition, many of them using alkynes as reaction partners.^[@ref3],[@ref4]^ These strategies represent very powerful alternatives to classical cycloadditions of unsaturated substrates and are especially attractive to ensemble heterocyclic products.^[@ref5]^

One of the landmark advances in this topic consists of the annulation between benzoic or acrylic acids and alkynes to give isocoumarin or α-pyrone products. This reaction has been performed using rhodium,^[@ref6]^ ruthenium,^[@ref7]^ and even cobalt complexes^[@ref8]^ and provides one of the simplest ways to ensemble these types of oxacyclic skeletons from simple precursors. Remarkably, despite the synthetic value of the reaction, we are not aware of the development of intramolecular variants. Tethering the alkyne to the acrylic or benzoic acid moiety would not only allow controlling the regioselectivity, which is an issue in the intermolecular processes, but also provide for a higher increase in skeletal complexity.

In 2013, we reported one of the first intramolecular formal annulations involving C--H activations. The reaction, shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}A, involved an acrylamide and a N-tethered alkyne and provided a practical entry to isoquinoline products.^[@ref9]^ In the case of the acrylic acid derivatives, the alkyne must be tethered to the carbon instead of the oxygen atom of the acid. The C--H activation would generate a rhodacycle, which after migratory insertion of the alkyne and reductive elimination should produce the bicyclic lactone adducts ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}B). Noteworthy, α-pyrones and related lactones fused to other rings are present in many natural products ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}C) and therefore the technology might find important synthetic applications in the future.

![Intramolecular Annulations and Natural Products with Polycyclic Pyrone Cores](ao-2019-00022j_0002){#sch1}

Herein, we present the first examples of intramolecular, formal (4 + 2) annulations between acrylic acids and alkynes.^[@ref10]^ The methodology can be extended to benzoic acids and pyrrole-3-carboxylic acids, providing for the assembly of interesting polycycles in just one catalytic step. Importantly, we also present preliminary examples on the manipulation potential of the resulting pyrones.

Results and Discussion {#sec2}
======================

The viability of the annulation was studied on precursor **1a**, readily assembled from phenylpropynol and methyl buta-2,3-dienoate (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00022/suppl_file/ao9b00022_si_001.pdf)). At the outset, we were concerned about the C--H activation step, as it might be compromised by the presence of substitution in the β-carbon of the acrylic acid moiety. However, we were pleased to find that the treatment of **1a** with 2.5 mol % \[Cp\*RhCl~2~\]~2~ in *tert*-amyl alcohol at 100 °C, using 2 equiv of copper diacetate as oxidant, generates the desired cycloadduct, which was isolated in 50% yield (entry 1, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Using dimethylformamide (DMF) as solvent, the yield was lower (entry 2); however, switching the oxidant to silver carbonate, we obtained the expected pyrone **2a** in 82% yield (entry 3).

###### Optimization of the Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao-2019-00022j_0005){#fx1}

  entry                               catalyst                             solvent   *T* (°C)   yield (%)
  ----------------------------------- ------------------------------------ --------- ---------- -----------------------------------------------------------------------
  1[b](#t1fn2){ref-type="table-fn"}   \[Cp\*RhCl~2~\]~2~                   *t*AmOH   100        50[b](#t1fn2){ref-type="table-fn"}
  2[b](#t1fn2){ref-type="table-fn"}   \[Cp\*RhCl~2~\]~2~                   DMF       120        25[b](#t1fn2){ref-type="table-fn"}
  **3**                               **\[Cp\*RhCl**~**2**~**\]**~**2**~   **DMF**   **120**    **82**[c](#t1fn3){ref-type="table-fn"}
  4                                   \[Cp\*RhCl~2~\]~2~                   DCE       80         20
  5                                   \[Cp\*RhCl~2~\]~2~                   toluene   110        36
  6                                   \[Cp\*RhCl~2~\]~2~                   MeOH      60         71
  7                                   \[(*p*-cymene)RuCl~2~\]~2~           DMF       120        28
  8                                   \[Cp\*IrCl~2~\]~2~                   DMF       120         
  9                                   \[Cp\*Rh(CH~3~CN)~3~\](SbF~6~)~2~    DMF       120        21[c](#t1fn3){ref-type="table-fn"}^,^[d](#t1fn4){ref-type="table-fn"}
  10                                  \[Cp\*RhCl~2~\]~2~                   DMF       120        31[e](#t1fn5){ref-type="table-fn"}

Reaction conditions: 0.20 mmol of **1a**, catalyst (2.5 mol %), 2 equiv of Ag~2~CO~3~, solvent (0.8 mL), 12 h. Yields determined by internal standard.

Cu(OAc)~2~·H~2~O (2 equiv) instead of Ag~2~CO~3~.

Isolated yield.

5 mol % of catalyst.

1 equiv of Ag~2~CO~3~.

With other solvents, such as 1,2-dichloroethane, toluene, or MeOH, we observed poorer conversions. Interestingly, using \[(*p*-cymene)RuCl~2~\]~2~ as catalyst, which had been previously used in intermolecular annulations, the yield was modest (entry 7), whereas with \[Cp\*IrCl~2~\]~2~, the starting material was fully recovered (entry 8). The cationic catalyst \[Cp\*Rh(CH~3~CN)~3~\](SbF~6~)~2~ also resulted in a less effective process (entry 9). The yield of the product was also lower when only 1 equiv of silver carbonate was used (entry 10).

With the optimized conditions at hand, we studied the scope with other precursors (see [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The reaction is also efficient with acrylic acid derivatives featuring longer connecting tethers and therefore products with 6- and 7-membered rings containing either a fully carbon chain or an ether were obtained in good yields (**2b--e**, 50--73%). Further enlarging the connection slows down the reaction and thus the 8-membered product **2f** was isolated in low yield (12%). The presence of an aliphatic substituent (*n*-Bu) instead of the phenyl ring in the alkyne is tolerated, albeit the yield was slightly lower (**2g**, 49%). A methyl group in the α-position of the acrylic acids does not compromise the reaction, and the expected adducts were obtained in good yields (**2h** and **2i**, 52--80%). We also found that the reaction is efficient with substrates containing other aromatic substituents at the alkyne, with either electron-rich (**2j** and **2k**, 75 and 90% yield) or electron-deficient groups (**2l**, 63% yield), as well as for heteroaromatic substituents (**2m** and **2n**, 56 and 73% yield). We have also tested the reaction in a precursor bearing a nitrogen atom in the connecting tether. The reaction worked, but the product **2o** was isolated in lower yield .

###### Substrate Scope for Substituted Acrylic Acids[a](#t2fn1){ref-type="table-fn"}

![](ao-2019-00022j_0008){#fx2}

![](ao-2019-00022j_0006){#fx3}

Conditions: 50 mg of **1**, 2 equiv of Ag~2~CO~3~, 2.5 mol % of \[Cp\*RhCl~2~\]~2~, DMF (0.3 M), 120 °C, 12 h. Isolated yields.

At this point, we also assayed the reaction with benzoic instead of acrylic acid derivatives. These precursors were readily synthetized from commercially available products in one or two steps (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00022/suppl_file/ao9b00022_si_001.pdf)). Using the same conditions as above, we obtained the expected products **2p** and **2q**, featuring 6- and 7-membered rings in 47 and 77% yields, respectively ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Interestingly, we also demonstrated that *N*-alkyl 3-carboxy pyrroles **1r** and **1s** participate in the process to give the corresponding adducts **2r** and **2s** featuring seven- and eight-membered rings in excellent yields (80 and 73% respectively). Pyrrole-fused polycyclic products are present in many natural compounds and therefore this methodology might provide an easy way to generate these types of structures.

###### Scope for Aromatic Substrates[a](#t3fn1){ref-type="table-fn"}

![](ao-2019-00022j_0010){#fx4}

![](ao-2019-00022j_0007){#fx5}

Conditions: 50 mg of **1**, 2 equiv of Ag~2~CO~3~, 2.5 mol % of \[Cp\*RhCl~2~\]~2~, DMF (0.3 M), 120 °C, 12 h. Isolated yields.

Although the above cycloadducts are of intrinsic interest, we envisioned that the pyrone structure might allow designed manipulations to obtain other relevant scaffolds. Therefore, the treatment of product **2e** with potassium hydroxide in ethanol at room temperature promoted a quantitative conversion to the keto-carboxylic acid **3**. Formally, the transformation of **1e** to **3** can be visualized as a cyclization/hydration process, something that does not seem to be easy to achieve using alternative technologies ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref11]^

![Hydrolysis of the α-Pyrone](ao-2019-00022j_0003){#sch2}

Moreover, the presence of a *cis*-diene in pyrone adducts suggested the possibility of performing Diels--Alder cycloadditions. Remarkably, the treatment of pyrone **2d**, prepared in a 2 mmol scale from **1d**, with 2 equiv of *N*-phenylmaleimide at 140 °C produced bis-adduct **4** in good yield and complete stereoselectivity. The structure of this pentacyclic adduct was confirmed by X-ray diffraction crystallography (see [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"} and [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

![X-ray structure of cycloadduct **4**. Hydrogens omitted for clarity.](ao-2019-00022j_0001){#fig1}

![Cascade Diels--Alder Processes\
Conditions: (a) 2.05 mmol of **1d**, 1.5 equiv of Ag~2~CO~3~, 2.5 mol % of \[Cp\*RhCl~2~\]~2~, DMF (10.2 mL, 0.2 M), 120 °C, 24 h, 77% yield.](ao-2019-00022j_0004){#sch3}

This surprising transformation can be explained in terms of a cascade process involving several Diels--Alder reactions.^[@ref12]^ An initial (4 + 2) Diels--Alder cycloaddition, even between electron-deficient partners, is followed by a retro-cycloaddition with concomitant extrusion of carbon dioxide. Finally, the resulting intermediate reacts with another equivalent of maleimide through a second Diels--Alder to form the polycyclic structure. Overall, the transformation of **1d** into **4** (two steps) conveys the formation of five carbon--carbon bonds and five cycles, therefore providing for an impressive increase in complexity with total atom economy.

Conclusions {#sec3}
===========

In summary, we have developed the first examples of intramolecular (4 + 2) annulations between acrylic acids and alkynes. The oxidative annulation is promoted by Rh(III) catalysts and allows for the straightforward assembly of bicyclic and tricyclic pyrone-containing adducts from simple precursors. We also presented preliminary demonstrations of relevant manipulations of the cycloadducts, including a remarkable thermal cycloaddition cascade in the presence of an electron-poor dienophile.

Experimental Section {#sec4}
====================

General Comments {#sec4.1}
----------------

Dry solvents were freshly distilled under argon from an appropriate drying agent before use. Dried *N*,*N*-dimethylformamide was purchased from Sigma-Aldrich and used without further purification. \[RhCp\*Cl~2~\]~2~ (99%) \[12354-85-7\] and Ag~2~CO~3~ (99%) \[534-16-7\] were purchased from Sigma-Aldrich. All other chemicals were purchased from Sigma-Aldrich, TCI, Alfa Aesar, and Strem-Chemicals and used without further purification. All reactions dealing with air and moisture-sensitive compounds were carried out in an oven-dried reaction flask under an argon atmosphere with dry solvents. The abbreviation "rt" refers to reactions carried out approximately at 23 °C. Reaction mixtures were stirred using Teflon-coated magnetic stirring bars. Reaction temperatures were maintained using Thermowatch-controlled silicone oil baths. Thin-layer chromatography (TLC) was performed on silica gel plates, and components were visualized by observation under UV light and/or by treating the plates with *p*-anisaldehyde or phosphomolybdic acid solutions, followed by heating. Flash chromatography was carried out on silica gel unless otherwise stated. Dryings were performed with anhydrous Na~2~SO~4~ or MgSO~4~. Concentration refers to the removal of volatile solvents via distillation using a Büchi rotary evaporator followed by residual solvent removal under high vacuum. Melting points (mp) were determined with an M-560 BÜCHI apparatus. NMR spectra were recorded in CDCl~3~ at 300 MHz (Varian), unless other solvents are specified. Carbon types and structural assignments were determined from distortionless enhancement by polarization transfer-NMR. NMR spectra were analyzed using MestreNova NMR data processing software ([www.mestrelab.com](www.mestrelab.com)). 1,3,5-Trimethoxybenzene was used as internal standard. The following abbreviations are used to indicate signal multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; dd, double doublet; ddd, doublet of doublet of doublets; td, triple doublet; dt, doublet of triplets; dq, doublet of quartet; m, multiplet; brs, broad singlet. Electrospray ionization mass spectra (ESI-MS) were acquired using an IT-MS Bruker AmaZon SL at CIQUS and also using chemical ionization (CI) electron impact (EI), electrospray ionization (ESI), or atmospheric-pressure chemical ionization (APCI) at the CACTUS facility of the University of Santiago de Compostela. The reactions were monitored by TLC.

General Procedure for the Annulation Reaction  {#sec4.2}
----------------------------------------------

An oven-dried Schlenk tube equipped with a septum and magnetic stirring bar was charged with acrylic or benzoic acid (0.23 mmol), bis(dichloro(pentamethylcyclopentadienyl)rhodium) (2.5 mol %), silver carbonate (0.46 mmol), and DMF (0.8 mL). The reaction mixture was then stirred at 120 °C. After 24 h, the reaction mixture was concentrated in vacuum. Purification of the crude product was done by flash chromatography on silica gel (1:10--1:3 EtOAc/hexane).

### 4-Phenyl-3*H*-furo\[3,4-*c*\]pyran-6(1*H*)-one (**2a**) {#sec4.2.1}

Dark-yellow solid, mp 117--118 °C (41 mg, 82%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.65--7.57 (m, 2H), 7.53--7.45 (m, 3H), 6.19--6.12 (m, 1H), 5.09 (s, 2H), 4.87 (d, *J* = 1.6 Hz, 2H) ^13^C NMR (75 MHz, CDCl~3~): δ 162.7 (C), 161.1 (C), 152.4 (C), 131.4 (C), 130.8 (CH), 129.1 (CH), 126.6 (CH), 116.1 (C), 104.4 (CH), 70.9 (CH~2~), 70.1 (CH~2~). High-resolution mass spectroscopy (HRMS) (EI-FIA-TOF): *m*/*z* calculated for C~13~H~10~O~3~ (\[M\]^+^) 214.0630, found 214.0636.

### 1-Phenyl-7,8-dihydropyrano\[4,3-*c*\]pyran-3(5*H*)-one (**2b**) {#sec4.2.2}

White solid, mp 128--129 °C (29.5 mg, 59%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.65--7.59 (m, 2H), 7.49--7.45 (m, 2H), 7.34--7.30 (m, 1H), 6.01 (s, 1H), 4.67 (d, *J* = 1.4 Hz, 2H), 3.83 (t, *J* = 5.7 Hz, 2H), 2.77 (t, *J* = 5.6 Hz, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 161.8 (CO), 154.6 (C), 130.4 (CH), 128.7 (CH), 128.6 (CH), 125.6 (C), 124.3 (C), 109.9 (C), 107.8 (CH), 67.3 (CH~2~), 65.5 (CH~2~), 25.3 (CH~2~). HRMS (ESI-FIA-TOF): *m*/*z* calculated for C~14~H~13~O~3~ (\[M + H\]^+^) 229.0857, found 229.0857.

### 1-Phenyl-5,6,7,8-tetrahydro-3*H*-isochromen-3-one (**2c**) {#sec4.2.3}

Light-yellow solid, mp 113--114 °C (25 mg, 50%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.60--7.51 (m, 2H), 7.47--7.38 (m, 3H), 6.08 (s, 1H), 2.70 (t, *J* = 5.9 Hz, 2H), 2.60 (t, *J* = 6.2 Hz, 2H), 1.82--1.61 (m, 4H). ^13^C NMR (75 MHz, CDCl~3~): δ 162.5 (C), 158.5 (C), 156.8 (C), 132.6 (C), 129.8 (CH), 128.9 (CH), 128.3 (CH), 114.0 (C), 111.4 (CH), 29.7 (CH~2~), 25.3 (CH~2~), 22.7 (CH~2~), 21.6 (CH~2~). Low-resolution mass spectrometry (LRMS) (*m*/*z*, CI) 227.2 (\[M+H\]^+^, 100), 213.2 (54), 199.2 (23), 105.1 (52). HRMS (EI-FIA-TOF): *m*/*z* calculated for C~15~H~14~O~2~ (\[M\]^+^) 226.0994, found 226.0980.

### 1-Phenyl-8,9-dihydro-7*H*-pyrano\[4,3-*c*\]oxepin-3(5*H*)-one (**2d**) {#sec4.2.4}

White solid, mp 91--92 °C (35.5 mg, 71%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.47--7.35 (m, 5H), 6.11 (s, 1H), 4.40 (s, 2H), 3.88 (t, *J* = 5.1 Hz, 2H), 2.78--2.69 (m, 2H), 1.78 (p, *J* = 5.2 Hz, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 161.9 (C), 158.0 (C), 157.6 (C), 132.4 (C), 129. 9 (CH), 128.9 (CH), 128.4 (CH), 116.8 (C), 112.5 (CH), 74.9 (CH~2~), 73.5 (CH~2~), 30.9 (CH~2~), 27.6 (CH~2~). HRMS (ESI-FIA-TOF): *m*/*z* calculated for C~15~H~13~O~3~ (\[M + H\]^+^) 243.1016, found 243.1016.

### 1-Phenyl-6,7,8,9-tetrahydrocyclohepta\[*c*\]pyran-3(5*H*)-one (**2e**) {#sec4.2.5}

White solid, mp 74--77 °C (36.5 mg, 73%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.50--7.39 (m, 5H), 6.11 (s, 1H), 2.68--2.62 (m, 2H), 2.60--2.54 (m, 2H), 1.80--1.63 (m, 6H). ^13^C NMR (75 MHz, CDCl~3~): δ 163.4 (C), 162.7 (C), 157.0 (C), 133.0 (C), 129.7 (CH), 129.1 (CH), 128.4 (CH), 118.9 (C), 111.9 (CH), 36.5 (CH~2~), 31.3 (CH~2~), 29.3 (CH~2~), 28.3 (CH~2~), 28.3 (CH~2~). HRMS (APCI-FIA-TOF): *m*/*z* calculated for C~16~H~17~O~2~ (\[M + H\]^+^) 241.1223, found 241.1223.

### 1-Phenyl-7,8,9,10-tetrahydropyrano\[4,3-*c*\]oxocin-3(5*H*)-one (**2f**) {#sec4.2.6}

Yellowish solid, mp 118--120 °C (6 mg, 12%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.53--7.40 (m, 5H), 6.14--6.07 (m, 1H), 4.69--4.62 (m, 2H), 3.86 (t, *J* = 4.9 Hz, 2H), 2.88 (t, *J* = 6.3 Hz, 2H), 1.81--1.64 (m, 4H). ^13^C NMR (75 MHz, CDCl~3~): δ 162.1 (C), 160.4 (C), 159.4 (C), 133.141 (C), 130.1 (CH), 129.1 (CH), 128.6 (CH), 115.8 (C), 110.4 (CH), 72.6 (CH~2~), 71.4 (CH~2~), 27.9 (CH~2~), 25.5 (CH~2~), 25.3 (CH~2~). LRMS (*m*/*z*, CI) 257.1 (\[M+H\]^+^, 100), 229.1 (6). HRMS (EI-FIA-TOF): *m*/*z* calculated for C~16~H~16~O~3~ (\[M\]^+^) 256.1099, found 256.1094.

### 4-Butyl-3*H*-furo\[3,4-*c*\]pyran-6(1*H*)-one (**2g**) {#sec4.2.7}

Viscous yellow oil (24.5 mg, 49%). ^1^H NMR (300 MHz, CDCl~3~): δ 6.01--6.00 (m, 1H), 4.81--4.79 (m, 1H), 4.79--4.77 (m, 1H), 2.42 (t, *J* = 7.5 Hz, 2H), 1.75--1.61 (m, 2H), 1.46--1.16 (m, 2H), 0.93 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (75 MHz, CDCl~3~): δ 163.3 (C), 160.5 (C), 157.7 (C), 116.3 (C), 103.5 (CH), 71.3 (CH~2~), 68.63 (CH~2~), 32.38 (CH~2~), 28.72 (CH~2~), 22.30 (CH~2~), 13.7 (CH~3~). HRMS (QI): *m*/*z* calculated for C~11~H~15~O~3~ (\[M + H\]^+^) 195.1021, found 195.1026.

### 4-Methyl-1-phenyl-6,7-dihydrocyclopenta\[*c*\]pyran-3(5*H*)-one (**2h**) {#sec4.2.8}

Reddish solid (26 mg, 52%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.77--7.66 (m, 2H), 7.49--7.33 (m, 3H), 2.95 (t, *J* = 7.3 Hz, 2H), 2.74 (t, *J* = 7.5 Hz, 2H), 2.14--2.00 (m, 5H). ^13^C NMR (75 MHz, CDCl~3~): δ 164.2 (C), 160.7 (C), 150.4 (C), 132.7 (C), 129.4 (CH), 128.6 (CH), 127.0 (CH), 120.1 (C), 116.8 (C), 31.5 (CH~2~), 30.7 (CH~2~), 25.7 (CH~2~), 13.3 (CH~3~). LRMS (*m*/*z*, CI) 227.0 (\[M+H\]^+^, 100), 199.0 (10). HRMS (EI-FIA-TOF): *m*/*z* calculated for C~15~H~14~O~2~ (\[M\]^+^) 226.0994, found 226.0995.

### 4-Methyl-1-phenyl-5,6,7,8-tetrahydro-3*H*-isochromen-3-one (**2i**) {#sec4.2.9}

Light-yellow solid, mp 84--87 °C (40 mg, 80%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.57--7.51 (m, 2H), 7.45--7.38 (m, 3H), 2.68--2.55 (m, 4H), 2.07 (s, 3H), 1.84--1.74 (m, 2H), 1.66--1.58 (m, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 163.7 (C), 153.8 (C), 151.9 (C), 133.0 (C), 129.6 (CH), 129.1 (CH), 128.4 (CH), 119.8 (C), 114.0 (C), 27.7 (CH~2~), 26.2 (CH~2~), 22.4 (CH~2~), 22.0 (CH~2~), 12.1 (CH~3~). LRMS (*m*/*z*, CI) 241.1 (\[M+H\]^+^,100), 213.1 (14). HRMS calculated for C~16~H~16~O~2~ 240.1150, found 240.1147. HRMS (EI-FIA-TOF): *m*/*z* calculated for C~16~H~16~O~2~ (\[M\]^+^) 240.1150, found 240.1147.

### 1-(3,5-Dimethylphenyl)-4-methyl-5,6,7,8-tetrahydro-3*H*-isochromen-3-one (**2j**) {#sec4.2.10}

Reddish solid (37.5 mg, 75%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.08 (s, 2H), 6.95 (s, 1H), 2.66--2.40 (m, 4H), 2.26 (s, 6H), 1.99 (s, 3H), 1.79--1.63 (m, 2H), 1.62--1.44 (m, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 163.7 (C), 154.0 (C), 152.0 (C), 137.8 (C), 132.6 (C), 131.1 (CH), 126.7 (CH), 119.2 (C), 113.7 (C), 27.8 (CH~2~), 26.3 (CH~2~), 22.4 (CH~2~), 22.1 (CH~2~), 21.4 (CH~3~), 12.1 (CH~3~). HRMS (EI-FIA-TOF): *m*/*z* calculated for C~18~H~20~O~2~ (\[M\]^+^) 268.1463, found 268.1470.

### 4-Methyl-1-(naphthalen-1-yl)-5,6,7,8-tetrahydro-3*H*-isochromen-3-one (**2k**) {#sec4.2.11}

Yellow solid, mp 94--96 °C (45 mg, 90%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.97--7.84 (m, 2H), 7.75--7.64 (m, 1H), 7.57--7.43 (m, 4H), 2.69 (t, *J* = 7.7 Hz, 2H), 2.21 (t, *J* = 6.4 Hz, 2H), 2.13 (s, 3H), 1.83--1.72 (m, 2H), 1.62--1.50 (m, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 163.9 (C), 153.5 (C), 151.7 (C), 133.8 (C), 131.3 (C), 130.5 (C), 130.2 (CH), 128.7 (CH), 128.2 (CH), 127.1 (CH), 126.4 (CH), 125.3 (CH), 125.2 (CH), 120.1 (C), 115.5 (C), 27.7 (CH~2~), 25.1 (CH~2~), 22.1 (CH~2~), 22.1 (CH~2~), 12.1 (CH~3~). HRMS (EI-FIA-TOF): *m*/*z* calculated for C~20~H~18~O~2~ (\[M\]^+^) 290.1307, found 290.1310.

### 4-Methyl-1-(4-(trifluoromethyl)phenyl)-5,6,7,8-tetrahydro-3*H*-isochromen-3-one (**2l**) {#sec4.2.12}

Yellow solid, mp 134--135 °C (31.5 mg, 63%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.69--7.66 (m, 4H), 2.69--2.55 (m, 4H), 2.12--2.06 (m, 3H), 1.87--1.72 (m, 2H), 1.71--1.57 (m, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 163.2 (C), 151.9 (C), 151.6 (C), 136.4 (C), 131.4 (C, q, *J* = 32.3 Hz), 129.5 (CH), 125.4 (CH, q, *J* = 3.7 Hz), 124.0 (CF~3~, q, *J* = 272.6 Hz), 120.9 (C), 115.0 (C), 27.7 (CH~2~), 26.1 (CH~2~), 22.3 (CH~2~), 21.9 (CH~2~), 12.2 (CH~3~). HRMS (EI-FIA-TOF): *m*/*z* calculated for C~17~H~15~F~3~O~2~ (\[M\]^+^) 308.1024, found 308.1006.

### 1-(Thiophen-3-yl)-7,8-dihydropyrano\[4,3-*c*\]pyran-3(5*H*)-one (**2m**) {#sec4.2.13}

Yellow solid (39.2 mg, 56%), mp 116--117 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 7.75 (dd, *J* = 3.0, 1.3 Hz, 1H), 7.49 (dd, *J* = 5.2, 1.3 Hz, 1H), 7.40 (dd, *J* = 5.1, 2.9 Hz, 1H), 5.97--5.90 (m, 1H), 4.62 (d, *J* = 1.6 Hz, 2H), 3.88 (t, *J* = 5.8 Hz, 2H), 2.81 (t, *J* = 5.8 Hz, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 161.4 (C), 154.6 (C), 153.7 (C), 133.3 (C), 127.7 (CH), 127.1 (CH), 126.2 (CH), 109.0 (C), 107.2 (CH), 67.4 (CH~2~), 65.3 (CH~2~), 25.2 (CH~2~). HRMS (APCI-FIA-TOF): *m*/*z* calculated for C~12~H~11~O~3~S (\[M + H \]^+^) 235.0424, found 235.0423.

### 1-(Thiophen-2-yl)-7,8-dihydropyrano\[4,3-*c*\]pyran-3(5*H*)-one (**2n**) {#sec4.2.14}

Yellow solid (51.1 mg, 73%), mp 142--143 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 7.63 (dd, *J* = 3.9, 1.0 Hz, 1H), 7.55 (dd, *J* = 5.1, 1.1 Hz, 1H), 7.16 (dd, *J* = 5.1, 3.8 Hz, 1H), 5.91 (s, 1H), 4.61 (d, *J* = 1.5 Hz, 2H), 3.94 (t, *J* = 5.9 Hz, 2H), 2.83 (t, *J* = 5.9 Hz, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 160.8 (C), 154.5 (C), 152.9 (C), 134.3 (C), 129.9 (CH), 129.6 (CH), 128.0 (CH), 108.3 (C), 107.0 (CH), 67.6 (CH~2~), 65.2 (CH~2~), 25.0 (CH~2~). HRMS (APCI-FIA-TOF): *m*/*z* calculated for C~12~H~11~O~3~S (\[M + H\]^+^) 235.0422, found 235.0423.

### 2-Benzyl-4-phenyl-2,3-dihydropyrano\[3,4-*c*\]pyrrol-6(1*H*)-one (**2o**) {#sec4.2.15}

Yellow amorphous solid (17.5 mg, 35%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.67--7.58 (m, 2H), 7.50--7.39 (m, 3H), 7.38--7.28 (m, 5H), 6.12 (s, 1H), 3.94 (s, 2H), 3.88 (s, 2H), 3.73 (s, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 162.63 (C), 161.5 (C), 137.9 (C), 131.8 (C), 130.5 (CH), 128.9 (CH), 128.8 (CH), 128.7 (C), 128.7 (CH), 127.7 (CH), 127.0 (CH), 116.9 (C), 106.1 (CH), 59.9 (CH~2~), 57.3 (CH~2~), 55.8 (CH~2~). HRMS (APCI-FIA-TOF): *m*/*z* calculated for C~20~H~18~NO~2~ (\[M + H\]^+^) 304.1329, found 304.1332.

### 4-Methyl-2,3-dihydro-6*H*-pyrano\[3,4,5-*de*\]chromen-6-one (**2p**) {#sec4.2.16}

White solid, mp 161--162 °C (23.5 mg, 47%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.7 (d, *J* = 7.8 Hz, 1H), 7.2 (t, *J* = 7.9 Hz, 1H), 7.1 (d, *J* = 8.0 Hz, 1H), 4.2 (t, *J* = 5.7 Hz, 2H), 2.7 (t, *J* = 5.8 Hz, 2H), 2.1 (s, 3H). ^13^C NMR (75 MHz, CDCl~3~): δ 162.2 (C), 152.0 (C), 147.5 (C), 128.1 (CH), 124.1 (C), 121.6 (CH), 120.9 (CH), 120.4 (C), 104.0 (C), 65.8 (CH~2~), 23.9 (CH~2~), 15.9 (CH~3~). HRMS (APCI-FIA-TOF): *m*/*z* calculated for C~12~H~11~O~3~ (\[M + H\]^+^) 202.0700, found 202.0703.

### 5-Phenyl-3,4-dihydro-2*H*,7*H*-oxepino\[4,3,2-*de*\]isochromen-7-one (**2q**) {#sec4.2.17}

White solid, mp 155--156 °C (38.5 mg, 77%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.96 (dd, *J* = 7.5, 1.7 Hz, 1H), 7.53--7.47 (m, 2H), 7.40--7.33 (m, 3H), 7.32--7.22 (m, 2H), 4.27 (t, *J* = 6.8 Hz, 2H), 2.86 (t, *J* = 6.4 Hz, 2H), 2.12 (p, *J* = 6.7 Hz, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 162.1 (C), 158.6 (C), 150.2 (C), 133.0 (C), 131.1 (C), 129.7 (CH), 129.2 (CH), 128.8 (CH), 128.5 (CH), 126.4 (CH), 124.3 (CH), 122.9 (C), 111.9 (C), 73.5 (CH~2~), 29.2 (CH~2~), 25.9 (CH~2~). HRMS (APCI-FIA-TOF): *m*/*z* calculated for C~18~H~15~O~3~ (\[M + H\]^+^) 279.1016, found 279.1016.

### 2-Methyl-5-phenyl-6,7,8,9-tetrahydro-3*H*-4-oxa-9*a*-azabenzo\[*cd*\]azulen-3-one (**2r**) {#sec4.2.18}

Yellowish solid, mp 193--194 °C, (40 mg, 80%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.52--7.46 (m, 2H), 7.43--7.34 (m, 3H), 6.50 (s, 1H), 4.16--4.10 (m, 2H), 2.89--2.81 (m, 2H), 2.36 (s, 3H), 2.11 (p, *J* = 6.6 Hz, 2H), 1.93 (p, *J* = 6.8 Hz, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 160.6 (C), 151.0 (C), 140.8 (C), 133.3 (C), 129.2 (CH), 128.9 (CH), 128.2 (CH), 124.8 (CH), 118.0 (C), 109.0 (C), 108.6 (C), 47.2 (CH~2~), 27.6 (CH~2~), 25.3 (CH~2~), 25.1 (CH~2~), 10.7 (CH~3~). HRMS (APCI-FIA-TOF): *m*/*z* calculated for C~18~H~18~NO~2~ (\[M + H\]^+^) 280.1340, found 280.1332.

### 2-Methyl-5-phenyl-7,8,9,10-tetrahydro-3*H*,6*H*-4-oxa-10*a*-azacycloocta\[*cd*\]inden-3-one (**2s**) {#sec4.2.19}

Light orange solid, mp 216--217 °C (36.5 mg, 73%). ^1^H NMR (300 MHz, CDCl~3~): δ 7.48--7.41 (m, 2H), 7.41--7.34 (m, 3H), 6.46 (s, 1H), 4.33--4.21 (m, 2H), 2.84 (t, *J* = 7.1 Hz, 2H), 2.38 (s, 3H), 1.95--1.76 (m, 4H), 1.58--1.46 (m, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 160.6 (C), 152.2 (C), 140.5 (C), 133.6 (C), 129.0 (CH), 129.0 (CH), 128.2 (CH), 125.2 (CH), 117.9 (C), 108.2 (C), 107.6 (C), 47.9 (CH~2~), 30.1 (CH~2~), 28.4 (CH~2~), 25.4 (CH~2~), 21.3 (CH~2~), 10.8 (CH~3~). HRMS (APCI-FIA-TOF): *m*/*z* calculated for C~19~H~20~NO~2~ (\[M + H\]^+^) 294.1488, found 294.1489.

Synthesis of Acid **3** {#sec4.3}
-----------------------

To a solution of 1-phenyl-6,7,8,9-tetrahydrocyclohepta\[*c*\]pyran-3(5*H*)-one (**2e**) (50 mg, 0.21 mmol) in EtOH (1 mL) was added a saturated aqueous solution of KOH (93.4 mg, 1.66 mmol, 10 M), and the reaction mixture was stirred for 4 h at room temperature. The mixture was poured into an ice bath, and then the solution was acidified by the addition of HCl (0.5 M). EtOAc (5 mL) was added and the layers were separated. The aqueous layer was extracted twice with EtOAc (2 × 5 mL), and the combined organic extracts were washed with brine, dried, and concentrated under reduced pressure. Purification of the crude product by flash chromatography on silica gel (1:5--3:1 EtOAc/hexane) afforded the desired product 2-(2-benzoylcyclohept-1-en-1-yl)acetic acid (**3**) (53 mg, 99% yield). ^1^H NMR (300 MHz, CDCl~3~): δ 7.84 (d, *J* = 7.0 Hz, 2H), 7.60 (t, *J* = 7.4 Hz, 1H), 7.47 (t, *J* = 7.5 Hz, 2H), 3.10 (s, 2H), 2.51--2.43 (m, 4H), 1.86--1.76 (m, 2H), 1.67--1.52 (m, 4H). ^13^C NMR (75 MHz, CDCl~3~): δ 202.1 (C), 172.6 (C), 142.4 (C), 135.9 (C), 134.0 (CH), 129.9 (CH), 128.9 (CH), 44.0 (CH~2~), 35.7 (CH~2~), 32.2 (CH~2~), 32.0 (CH~2~), 26.5 (CH~2~), 25.8 (CH~2~). HRMS (APCI-FIA-TOF): *m*/*z* calculated for C~16~H~19~O~3~ (\[M + H\]^+^) 259.1324, found 259.1329.

Procedure for a Large-Scale Catalytic Annulation of **1d** {#sec4.4}
----------------------------------------------------------

An oven-dried Schlenk tube equipped with a septum and magnetic stirring bar was charged with (*E*)-4-((5-phenylpent-4-yn-1-yl)oxy)but-2-enoic acid (500.0 mg, 2.05 mmol), bis(dichloro(pentamethylcyclopentadienyl)rhodium) (32 mg, 0.05 mmol), silver carbonate (850 mg, 3.08 mmol), and DMF (7 mL). The reaction mixture was then stirred at 120 °C. After 24 h, the reaction mixture was concentrated in vacuum. Purification of the crude product by flash chromatography on silica gel (1:10--1:3 EtOAc/hexane) afforded 384 mg of 4-phenyl-3*H*-furo\[3,4-*c*\]pyran-6(1*H*)-one (**2d**) (77% yield).

Procedure for the Cascade Diels--Alder Reaction {#sec4.5}
-----------------------------------------------

An oven-dried sealed tube equipped with a magnetic stirring bar was charged with *N*-phenylmaleimide (75.2 mg, 0.43 mmol), 1-phenyl-8,9-dihydro-7*H*-pyrano\[4,3-*c*\]oxepin-3(5*H*)-one (**2d**) (30 mg, 0.12 mmol), and dioxane (1 mL). The reaction mixture was then stirred at 140 °C. After 36 h, the reaction mixture was concentrated in vacuo. Purification of the crude product by flash chromatography on silica gel (1:10--2:1 EtOAc/hexane) afforded the desired product as a white solid (65.5 mg, 97% yield). White solid, mp 249--250 °C. ^1^H NMR (300 MHz, CDCl~3~): δ 7.51--7.33 (m, 11H), 7.29--7.22 (m, 4H), 4.27 (s, 2H), 3.76 (t, *J* = 6.2 Hz, 2H), 3.69 (t, *J* = 3.0 Hz, 1H), 3.44 (d, *J* = 8.3 Hz, 2H), 3.16 (dd, *J* = 8.3, 3.0 Hz, 2H), 2.54--2.45 (m, 2H), 1.69--1.57 (m, 2H). ^13^C NMR (75 MHz, CDCl~3~): δ 175.3 (C), 173.9 (C), 139.1 (C), 139.0 (C), 134.6 (C), 131.6 (C), 131.0 (CH), 129.3 (CH), 128. 9 (CH), 127.8 (CH), 126.8 (CH), 126.3 (CH), 71.1 (CH~2~), 70.9 (CH~2~), 53.8 (C), 48.1 (CH), 44.0 (CH), 37.5 (CH), 30.4 (CH~2~), 29.3 (CH~2~). HRMS (APCI-FIA-TOF): *m*/*z* calculated for C~35~H~25~N~6~O~2~ (\[M + H\]^+^) 545.2071, found 545.2084.
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